Business · 28/05/2026
FDA Extends Comment Period for AI-Enabled Clinical Trials Pilot Program
The FDA is extending the comment period for a notice on using artificial intelligence to improve early-phase clinical trials, in response to a request for an extension, to gather more input from interested persons.